Crystalys Therapeutics
Clinical trials sponsored by Crystalys Therapeutics, explained in plain language.
-
New drug trial aims to shrink painful gout lumps
Disease control Recruiting nowThis study is testing whether a new medication called dotinurad works better than the standard drug allopurinol to lower uric acid and shrink painful lumps (tophi) in people with severe gout. It will involve about 250 adults with tophaceous gout who have visible lumps on their ha…
Phase: PHASE3 • Sponsor: Crystalys Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New gout drug aims to outperform standard treatment
Disease control Recruiting nowThis study is testing whether a new medication called dotinurad works better than the standard drug allopurinol at lowering uric acid levels in people with gout. It will involve about 500 adults who have had multiple gout flares and are already taking allopurinol. Researchers wil…
Phase: PHASE3 • Sponsor: Crystalys Therapeutics • Aim: Disease control
Last updated Mar 11, 2026 14:54 UTC